These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9432468)

  • 1. The future of positron emission tomography in oncology depends on interactive basic, nuclear and clinical research.
    Buell U; Cremerius U; Zimny M
    Eur J Nucl Med; 1997 Oct; 24(10):1330. PubMed ID: 9432468
    [No Abstract]   [Full Text] [Related]  

  • 2. [Whole body positron emission tomography (PET) with (18F)-fluorodeoxyglucose].
    Grupo PET de la SEMN
    Rev Esp Med Nucl; 2002 Apr; 21(2):128-30. PubMed ID: 11879625
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical PET: are we ready?
    Coleman RE; Tesar RD
    J Nucl Med; 1997 Dec; 38(12):16N, 24N. PubMed ID: 9430451
    [No Abstract]   [Full Text] [Related]  

  • 4. Lesion detectability and quantitative recovery with FDG-PET.
    Links JM
    Eur J Nucl Med; 1999 Jun; 26(6):681-2. PubMed ID: 10428608
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recommendations for the use of PET-CT with 18F-FDG in radiotherapy planning].
    García Vicente AM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):364. PubMed ID: 23063325
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical PET in oncology: not only FDG.
    Nanni C; Rubello D; Al-Nahhas A; Fanti S
    Nucl Med Commun; 2006 Sep; 27(9):685-8. PubMed ID: 16894321
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased glucose uptake by seborrheic keratosis detected by positron emission tomography.
    Ibusuki A; Higashi Y; Kanekura T
    J Dermatol; 2011 Jan; 38(1):104-5. PubMed ID: 21175767
    [No Abstract]   [Full Text] [Related]  

  • 8. Injected dose in pediatric PET.
    Watson CC
    J Nucl Med; 2010 Oct; 51(10):1657; author reply 1657-8. PubMed ID: 20847164
    [No Abstract]   [Full Text] [Related]  

  • 9. Positron emission tomography: background, possibilities and perspectives in neuroscience.
    Paans AM
    Acta Neurol Belg; 1997 Sep; 97(3):150-3. PubMed ID: 9345585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings of a National Cancer Institute workshop: PET in oncology--a clinical research agenda.
    Wahl RL; Hawkins RA; Larson SM; Hendee WR; Coleman RE; Holden RW; Frick MP; Gatsonis C; Brown GS; Shtern F
    Radiology; 1994 Dec; 193(3):604-6. PubMed ID: 7972793
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cerebral positron emission tomography with F18-fluorodeoxyglucose].
    Grupo PET de la SEMN.
    Rev Esp Med Nucl; 2002 Feb; 21(1):38-40. PubMed ID: 11821002
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a future for PET in oncology?
    Price P
    Eur J Nucl Med; 1997 Jun; 24(6):587-9. PubMed ID: 9235296
    [No Abstract]   [Full Text] [Related]  

  • 13. New 18F-radiopharmaceuticals.
    Stöcklin G
    Nuklearmedizin; 1990 Mar; 29(2):80. PubMed ID: 2339087
    [No Abstract]   [Full Text] [Related]  

  • 14. SNM clinical trials network validates 100th scanner.
    Graham M; Conti P; Hoffman J
    J Nucl Med; 2011 Jun; 52(6):25N. PubMed ID: 21622892
    [No Abstract]   [Full Text] [Related]  

  • 15. 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease.
    Skehan SJ; Issenman R; Mernagh J; Nahmias C; Jacobson K
    Lancet; 1999 Sep; 354(9181):836-7. PubMed ID: 10485733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine.
    Schelbert HR; Hoh CK; Royal HD; Brown M; Dahlbom MN; Dehdashti F; Wahl RL
    J Nucl Med; 1998 Jul; 39(7):1302-5. PubMed ID: 9669415
    [No Abstract]   [Full Text] [Related]  

  • 17. The incremental value of diagnostic tests.
    Wagner HN
    J Nucl Med; 1997 Feb; 38(2):241-2. PubMed ID: 9025745
    [No Abstract]   [Full Text] [Related]  

  • 18. Positron emission tomography in cancer patient management.
    Wahl RL
    Cancer J Sci Am; 1999; 5(4):205-7. PubMed ID: 10439163
    [No Abstract]   [Full Text] [Related]  

  • 19. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations.
    Gordon BA; Flanagan FL; Dehdashti F
    AJR Am J Roentgenol; 1997 Dec; 169(6):1675-80. PubMed ID: 9393189
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nuclear medicine in oncology: new diagnostic and therapeutic methods].
    Maublant J; Lumbroso J; Cachin F; Raoul JL; Syrota A; Vuillez JP
    Bull Cancer; 2001 Jan; 88(1):35-44. PubMed ID: 11182651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.